Close
ACHEMA MIDDLE EAST 2026

Pharma Alliance Worth $5 Billion In Bispecific Antibodies

Ivonescimab (PD-1/VEGF, AK112), a ground-breaking bispecific antibody, will be out-licensed by Biopharma Akeso Inc. to Summit Therapeutics Inc. for use in research and development...

Etihad Cargo Joins Forces With A New Cold Storage Facility

A new cold chain facility being built by Etihad Cargo, Etihad Airport Services, and Abu Dhabi Airports will more than increase the carrier's pharmaceutical...

India Seeks Better Pharma Market Access In The UK: Official

As a part of the proposed free trade deal with Britain, India is looking at expanding access to markets for its pharmaceutical products in...

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

Pharma confidence in growth, innovation, and process efficiency has reached record highs, according to the results of the CPhI's 2022 Pharma Index poll, which...

CPHI Report Says, Biologics Outsourcing Will Surge In 2023

Part I of the CPHI Annual Report looks ahead at the potential for biologics outsourcing and contract manufacturing organisations (CMOs) in 2023 in advance...

Gates Foundation Commits $1.2 Billion To Root Out Polio

The Bill & Melinda Gates Foundation pledged $1.2 billion at the World Health Summit in anticipation of the polio pledging event. With this funding, Bio Farma's...

RNA Vaccine UK Innovation Centre At CPI Gets Fresh Funding

The Centre for Process Innovation (CPI) received a grant of £10.65 million to assist its work in the research, scale-up, and manufacture of RNA...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...